Late Breaking Abstract - Characteristics and treatment of patients with comorbid COPD and heart failure

D. Price (Singapore, Singapore), R. Ryan (Singapore, Singapore), R. Fogel (East Hanover, NJ, United States of America), H. Cao (East Hanover, NJ, United States of America), J. W.H. Kocks (singapore, Singapore), P. Agostoni (Milan, Italy), C. Kook Rhee (Seoul, Republic of Korea), J. Hurst (London, United Kingdom), R. Jones (Singapore, Singapore), K. Kostikas (Basel, Switzerland)

Source: International Congress 2018 – COPD exacerbations and bronchiectasis
Session: COPD exacerbations and bronchiectasis
Session type: Thematic Poster
Number: 4087
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Price (Singapore, Singapore), R. Ryan (Singapore, Singapore), R. Fogel (East Hanover, NJ, United States of America), H. Cao (East Hanover, NJ, United States of America), J. W.H. Kocks (singapore, Singapore), P. Agostoni (Milan, Italy), C. Kook Rhee (Seoul, Republic of Korea), J. Hurst (London, United Kingdom), R. Jones (Singapore, Singapore), K. Kostikas (Basel, Switzerland). Late Breaking Abstract - Characteristics and treatment of patients with comorbid COPD and heart failure. 4087

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Late Breaking Abstract - Determinants of disease control in patients with severe COPD. The CLAVE Study
Source: International Congress 2019 – Clinical approach to asthma management
Year: 2019


Late Breaking Abstract - Relationship between clinical features and mortality in a cohort of COPD patients.
Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD
Year: 2021


Prediction of chronic renal failure in patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – COPD: points to ponder
Year: 2014


Late Breaking Abstract - Co-morbid disease clusters in chronic obstructive pulmonary disease: the ERICA study
Source: International Congress 2017 – New trends in pulmonary rehabilitation and chronic care
Year: 2017



Cognitive dysfunction is greater in patients hospitalised with COPD exacerbations than with worsening heart failure
Source: International Congress 2014 – Markers
Year: 2014


Neglected COPD and chronic comorbidities in elderly patients with chronic heart failure
Source: Annual Congress 2008 - COPD and comorbidities
Year: 2008


Acute myocardial infarction among Spanish adults with and without COPD: Cumulative incidence and outcomes
Source: International Congress 2014 – COPD markers
Year: 2014

COPD and co-existent chronic heart failure (CHF): Response to pulmonary rehabilitation (PR)
Source: International Congress 2016 – New insights into pulmonary rehabilitation for chronic lung diseases
Year: 2016


Chronic obstructive pulmonary disease and myocardial infarction: Special aspects of clinical course in comorbid conditions
Source: International Congress 2014 – Predictors
Year: 2014


Late Breaking Abstract - Does medication exacerbate comorbidities in chronic obstructive pulmonary disease? A prevalence study of neuroleptic intake
Source: International Congress 2018 – COPD exacerbations and bronchiectasis
Year: 2018


Metabolic syndrome in patients with COPD
Source: International Congress 2014 – Clinical presentations
Year: 2014

Relationship between dyspnea and depression in the elderly patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – COPD: points to ponder
Year: 2014

Evaluation of arrhythmia frequency in patients with COPD
Source: International Congress 2015 – Different data in COPD
Year: 2015


Late Breaking Abstract - Tiotropium/olodaterol improves pulmonary function in patients with treatment naive COPD
Source: International Congress 2019 – COPD clinical trials: inhaled and oral therapies
Year: 2019


Prevalence of comorbidities in patients with chronic obstructive pulmonary disease in presence of heart failure
Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Year: 2016


Prevalence of chronic ischaemic heart disease in idiopathic pulmonary fibrosis: A single center study
Source: International Congress 2014 – Clinical management of interstitial lung diseases and vasculitis
Year: 2014


Mortality associated with the type of heart failure in patients with chronic obstructive pulmonary disease
Source: International Congress 2016 – COPD and asthma COPD overlap syndrome (ACOS): novelties in terms of prevalence, risk factors, and prognosis in COPD
Year: 2016


Characteristics of essential hypertension in COPD patients
Source: International Congress 2014 – COPD: points to ponder
Year: 2014


COPD as undetected cause of dyspnea in patients admitted with ischaemic heart disease (IHD)
Source: International Congress 2014 – COPD: points to ponder
Year: 2014


LATE-BREAKING ABSTRACT: Risk factors for hospitalization and death in elderly smokers with chronic obstructive pulmonary disease (COPD) and/or chronic heart failure (CHF)
Source: International Congress 2016 – Long-term oxygen therapy, noninvasive ventilation, and other clinical variables in chronic lung diseases
Year: 2016